Revolution Medicines, Inc. (RVMD) Stock News & Chart | StockAdder

(RVMD)

Revolution Medicines, Inc.

Stock chart and latest news for Revolution Medicines, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Revolution Medicines, Inc. News

PRO

Cancer drug developer Revolution Medicines locks in $2B financing

Apr 15, 2026 Barron's

Revolution Medicines Stock Is Soaring 39%. Here’s Why.

Apr 13, 2026 Quiver Quantitative

Revolution Medicines Announces Pricing of $1.5 Billion Common Stock and Convertible Note Offerings

Apr 15, 2026 Seeking Alpha

Revolution Medicines: "Strong Buy" On Daraxonrasib Win And Expansions Underway (RVMD)

Apr 14, 2026 CNBC

Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial

Apr 13, 2026 MarketBeat

Investors Purchase High Volume of Revolution Medicines Call Options (NASDAQ:RVMD)

Apr 14, 2026 Investorideas.com

Why Did Oncology Stock Revolution Medicines (RVMD) Gain 41% Monday?

Apr 14, 2026 Yahoo Finance UK

Revolution Medicines (RVMD) Soars to All-Time High on Stellar Cancer Treatment Trial

Apr 14, 2026 TradingKey

Revolution Medicines Doubles Pancreatic Cancer Survival in Phase 3 Trial — Is RVMD Stock a Buy at $136?

Apr 14, 2026 TipRanks

Why Did Revolution Medicines (RVMD) Stock Soar Today?

Apr 13, 2026 GuruFocus

Revolution Medicines (RVMD) Stock Surges 38.7%

Apr 13, 2026 Stock Titan

Once-daily pill beat IV chemotherapy in metastatic pancreatic cancer